Wallenberg’s Investor is the first of the major companies to show the effects of new accounting regulations. The company now has to try and assess the market value of its unlisted holdings.
“It’s not that easy but we’ve done the best we can,” said finance director Lars Wedenborn at a press conference yesterday. Investor reported income before tax of 8,332 million crowns for 2004, compared to 1,003 million crowns for 2003.
Crestor continues to fall
Astra Zeneca’s cholesterol-lowering drug Crestor is continuing to lose market share in the US. Its share dropped by 0.2 per cent to 5.5 per cent during the first week of this year compared to the last week of 2004. The drop is thought to be connected with reports of a possible death of a patient in the UK who was being treated with the drug.
Supplied by BECK TRANSLATIONS.
With an experienced team of in-house translators, Beck specialises in translating from Swedish into English in such areas as finance and economics, marketing and advertising, biotechnology, the environment, quality, and personnel & administration.